SABBY MANAGEMENT, LLC

Average Profitability
<0.0001%
Insider Buys Quantity
28
Insider Buys Sum
$937,194.46
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of SABBY MANAGEMENT, LLC

The largest purchase of all time was on 2014-04-08 and amounted to 35500 shares of Akari Therapeutics, Plc for $190,280.

Biography of SABBY MANAGEMENT, LLC

No biography is available at this moment.

2019-01-31PurchaseReShape Lifesciences Inc.
RSLS
10 percent owner
10,301
0.0019%
$0.27$2,815-80.6%
2019-01-30PurchaseReShape Lifesciences Inc.
RSLS
10 percent owner
48,000
0.0096%
$0.28$13,440-77.28%
2019-01-29PurchaseReShape Lifesciences Inc.
RSLS
10 percent owner
12,200
0.0024%
$0.28$3,390-75.93%
2019-01-25PurchaseReShape Lifesciences Inc.
RSLS
10 percent owner
15,595
0.003%
$0.27$4,237-74.71%
2019-01-24PurchaseReShape Lifesciences Inc.
RSLS
10 percent owner
6,190
0.0011%
$0.26$1,578-74.56%
2019-01-22PurchaseReShape Lifesciences Inc.
RSLS
10 percent owner
5,766
0.0012%
$0.28$1,609-72.71%
2019-01-18PurchaseReShape Lifesciences Inc.
RSLS
10 percent owner
24,334
0.0048%
$0.28$6,787-73.44%
2019-01-17PurchaseReShape Lifesciences Inc.
RSLS
10 percent owner
52
<0.0001%
$0.28$15-72.49%
2019-01-16PurchaseReShape Lifesciences Inc.
RSLS
10 percent owner
26,661
0.0051%
$0.27$7,172-72.96%
2019-01-15PurchaseReShape Lifesciences Inc.
RSLS
10 percent owner
167,760
0.028%
$0.24$39,440-73.07%
2014-04-15PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
17,100
0.3007%
$5.00$85,500+9.59%
2014-04-14PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
3,000
0.0539%
$5.21$15,630+7.49%
2014-04-11PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
100
0.0017%
$5.15$515+3.7%
2014-04-10PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
1,400
0.0252%
$5.25$7,350+6.67%
2014-04-09PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
1,075
0.0194%
$5.51$5,923+1.82%
2014-04-08PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
35,500
0.6218%
$5.36$190,280+1.82%
2014-04-07PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
20,654
0.3716%
$5.71$117,840-1.75%
2014-04-04PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
12,250
0.216%
$6.07$74,400-9.53%
2014-04-02PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
2,500
0.0441%
$6.15$15,375-10.69%
2014-04-01PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
15,371
0.2742%
$6.10$93,806-8.94%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.